A comparator product is a reference agent, placebo, or standard-of-care treatment that is used as the control arm in a clinical trial to evaluate the relative efficacy and safety of an investigational product. In trial protocols, clinical study reports, and regulatory labeling documentation, it defines the baseline against which outcomes are measured and determines how treatment differences should be interpreted.
In translation and localization, comparator product terms appear in clinical trial protocols, investigator brochures, clinical study reports, and informed consent documents. Translators must preserve the type of comparator, dose, route, blinding status, and whether it is an active comparator, placebo, or standard-of-care arm, so that the trial design remains unambiguous.
A frequent mistake is translating “comparator product” as “comparison product” or “reference product” without distinguishing it from a generic reference product, which can blur the trial control context. Mixing up active comparator and placebo comparator terms in the same file also changes the meaning of efficacy and safety comparisons.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →